FUTURA INKS AGREEMENT WITH GSK TO DEVELOP NON-PRESCRIPTION TREATMENT FOR ED

Futura Medical plc, the pharmaceutical drug and medical device group that develops innovative products for sexual health, announced that it has entered into a development agreement with GlaxoSmithKline Consumer Healthcare (GSK-CH) for Futura's topically applied gel (MED2002) for the treatment of erectile dysfunction (ED). GSK-CH is a division of GSK plc, the global pharma and healthcare group.

PharmaBiz (http://pharmabiz.com/article/detnews.asp?articleid=34146)